Role of surface complexed iron in oxidant generation and lung inflammation induced by silicates.
Inhalation of silicates induces a variety of lung diseases in humans. The molecular mechanism(s) by which these dusts cause disease is not known. Because several naturally occurring mineral oxides have large amounts of transition metal ions on their surfaces, we tested the hypothesis that surface complexation of iron may be an important determinant of their ability to induce disease. Silica, crocidolite, kaolinite, and talc complexed considerable concentrations of Fe3+ onto their surfaces from both in vitro and in vivo sources. The potential biological importance of iron complexation was assessed by examining the relationship between surface [Fe3+] and the ability of silicates to mediate oxidative degradation of deoxyribose in vitro, induce a respiratory burst and elicit leukotriene B4 (LTB4) release by alveolar macrophages (AM) in vitro, and cause acute alveolitis after intratracheal insufflation. For these studies, three varieties of silicate dusts were used: iron-loaded, wetted (unmodified), and deferoxamine-treated to remove Fe3+. The ability of silicates to catalyze oxidant generation in an ascorbate/H2O2 system in vitro, to trigger respiratory burst activity and LTB4 release by AM, and to induce acute lung inflammation in the rat all increased with surface complexed Fe3+. The results of these studies suggest that surface complexation of iron may be an important determinant in the pathogenesis of disease after silicate exposure.
Ghio
A J
AJ
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Kennedy
T P
TP
Whorton
A R
AR
Crumbliss
A L
AL
Hatch
G E
GE
Hoidal
J R
JR
D000327:Adsorption; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000378:metabolism; D003676:Deferoxamine / Q000494:pharmacology; D004391:Dust; D007501:Iron / Q000378:metabolism*; D007975:Leukotriene B4 / Q000378:metabolism; D016676:Macrophages, Alveolar / Q000378:metabolism; D008297:Male; D008903:Minerals / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D011014:Pneumonia / Q000139:chemically induced*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism*; D012824:Silicic Acid / Q000378:metabolism*; D012822:Silicon Dioxide; D013499:Surface Properties
D004391:Dust; D008903:Minerals; D017382:Reactive Oxygen Species; D012824:Silicic Acid; D007975:Leukotriene B4; D012822:Silicon Dioxide; D007501:Iron; D003676:Deferoxamine